Adma Biologics: Q1 Earnings Snapshot
Posted May 13, 2021 05:24:05 AM.
Last Updated May 13, 2021 05:25:22 AM.
RAMSEY, N.J. (AP) _ Adma Biologics Inc. (ADMA) on Wednesday reported a loss of $18.4 million in its first quarter.
The Ramsey, New Jersey-based company said it had a loss of 16 cents per share.
The results exceeded Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 17 cents per share.
The infectious disease drug developer posted revenue of $16 million in the period, also topping Street forecasts. Three analysts surveyed by Zacks expected $15.6 million.
The company’s shares closed at $1.67. A year ago, they were trading at $2.55.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ADMA at https://www.zacks.com/ap/ADMA
The Associated Press
